Chicago Trust’s Sanofi SNY Stock Holding History

Chicago Trust’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,000	Closed	-$401K	–	354
2021 Q4	$401K	Hold	8,000	–	–	0.08%	231
2021 Q3	$386K	Hold	8,000	–	–	0.08%	225
2021 Q2	$421K	Buy	+8,000	New	+$417K	0.1%	201
2021 Q1	–	Sell	-8,000	Closed	-$389K	–	231
2020 Q4	$389K	Buy	+8,000	New	+$395K	0.13%	150

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Chicago Trust's SNY Position: Q1 2022 in Review

Chicago Trust sold out of Sanofi (SNY) in Q1 2022, closing a stake of 8,000 shares — an estimated $401K sold.

Chicago Trust first reported a position in SNY in Q4 2020 and held it in 4 quarters. The position peaked at $421K in Q2 2021. 623 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

Chicago Trust reported no remaining Sanofi position as of Q1 2022 after selling out during the quarter.
Chicago Trust sold 8,000 Sanofi shares in Q1 2022, an estimated $401K.
Chicago Trust first reported a position in Sanofi in Q4 2020 and held it in 4 quarters.
Chicago Trust's Sanofi position peaked at $421K in Q2 2021.
623 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on Chicago Trust's 13F filing for Q1 2022, filed 12 Apr 2022.